Table 2. Response Rates and Long-Term Outcomes with FCR3.

Response	N (%)	Flow MRD negative, n/N (%)	Median TTP (months)	Median OS (months)	9-year survival (%)
All patients	65 (100)	37/60 (62)	81	Not reached	58
Any response (CR + nPR + PR)	62 (97)	37/59 (63)	82	Not reached	61
CR	48 (75)	34/46 (74)	86	Not reached	65
nPR	10 (16)	1/9 (11)	49	Not reached	60
PR	4 (6)	2/4 (50)	--	41	25

MRD, minimal residual disease; TTP, time to progression; OS, overall survival; CR, complete response; nPR, nodular partial response; PR, partial response